ClinicalTrials.govpublic full text
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
hodgkin lymphoma, dacarbazine, doxorubicin/adriamycin, sgn-35 (brentuximab vedotin), vinblastine, involved-site radiation therapy (isrt), early stage, 13-034, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 918457
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.